Neuland Laboratories Limited will host its Q1FY27 earnings conference call on August 5, 2026, at 17:30 IST. The company announced the schedule to provide investors with an opportunity to discuss its financial performance for the quarter ended June 30, 2026. This disclosure ensures transparency regarding the firm's operational and financial outcomes for the initial period of the fiscal year.

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015. Neuland Laboratories Limited submitted the intimation to both the Bombay Stock Exchange and the National Stock Exchange of India Ltd on July 28, 2026. The filing was signed by Sarada Bhamidipati, the Company Secretary, confirming the details for regulatory records.

Call Details

Investors interested in participating in the earnings discussion must register through the official link provided by the company. The webcast will allow stakeholders to hear management commentary on the quarterly results. Key details of the event are outlined below:

About Neuland Laboratories

Neuland Laboratories Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs) with over four decades of industry experience. The company operates cGMP manufacturing facilities and serves customers in approximately 80 countries. It has developed more than 300 processes and 100 APIs, supported by around 1,010 regulatory filings across the US, European Union, and other geographies.

The firm holds cGMP certifications from major health authorities including the U.S. FDA, TGA (Australia), EDQM (EU), German Health Authority, ANVISA (Brazil), EMA (EU), Cofepris (Mexico), KFDA (Korea), PMDA (Japan), CFDA (China), FSI "SID & GP" Russia, and Health Canada. Additional certifications include ISO 9001, ISO14001, OHSAS18001, and ISO 27001.

For further queries, investors may contact the Investor Relations team at ir@neulandlabs.com or reach out to Runjhun Jain and Minakshi Machutre at EY.

Neuland Laboratories Limited has scheduled its 42nd Annual General Meeting (AGM) for August 4, 2026, at 10:00 a.m. IST through Video Conferencing (VC) and Other Audio Visual Means (OAVM). The meeting will cover the adoption of audited financial statements for the financial year ended March 31, 2026, and the declaration of a final dividend. Shareholders will also consider the appointment of a new director and the ratification of remuneration for cost auditors.

The Board of Directors has recommended a final dividend of ₹34 per share, or 340%, for the financial year 2025-26. This dividend is payable on or after August 11, 2026, to members whose names appear on the Register of Members as of July 24, 2026, which serves as the record date. The dividend distribution is subject to approval by the shareholders at the AGM.

Special Business Agenda

The AGM will include special business items, primarily the appointment of Dr. Mauricio Futran (DIN: 11699767) as a Non-Executive Non-Independent Director of the Company. Dr. Futran, who was appointed as an Additional Director on May 12, 2026, brings over 40 years of experience in strategic process and product development. His appointment is liable to retire by rotation.

Shareholders will also vote on a resolution to pay commission to Non-Executive Directors, not exceeding 1% of the net profits of the Company for each year, for a period of five years commencing from the financial year 2026-27. Additionally, the meeting seeks approval for the payment of professional fees to Dr. Futran for his services on the Scientific Advisory Board and as a technical consultant.

Cost Auditor Ratification

Another key resolution involves the ratification of the remuneration of the Cost Auditors. The Board has approved the re-appointment of M/s. Nageswara Rao & Co., Cost Accountants, to audit the cost records for the financial year ending March 31, 2027. The ratification seeks approval for a remuneration of ₹4,00,000 plus applicable taxes and out-of-pocket expenses.

Key Meeting Details

The facility for remote e-voting will be available to members holding shares as of July 28, 2026. The Company has engaged National Securities Depository Limited (NSDL) to facilitate the e-voting process. Members can attend the AGM virtually through the NSDL e-Voting system.